Klox Technologies Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Klox Technologies Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014258
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Klox Technologies Inc (Klox Technologies) is a specialty pharmaceutical company, which focuses on the development and commercialization of a proprietary BioPhotonic technology platform. Its pipeline portfolio includes non-invasive wound care treatment solutions, dermatological treatment solutions and adjunct treatment to scaling and root planning. The company’s technology platform is a non-invasive, pathology-specific topical treatment platform which uses the power of light and photo-activated, oxygen-rich gel formulations to treat a wide range of skin and soft tissue disorders. The company carries out research in dermatology, wound care, oral care and cosmetology. The company has collaborations with LEO Pharma A/S to commercialize its technology platform in the field of dermatology. The company has operational presence in Canada and Italy. Klox Technologies is headquartered in Laval, Quebec, Canada.

Klox Technologies Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Klox Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Klox Technologies Inc, Medical Devices Deals, 2011 to YTD 2017 9
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Leo Pharma Enters into Licensing Agreement with Klox Technologies 11
Klox Technologies Enters Into Licensing Agreement With Sandoz Canada 12
Klox Technologies and LEO Pharma to Form Joint Venture 13
Licensing Agreements 14
Colgate-Palmolive Enters into Licensing Agreement with Klox Technologies 14
Equity Offering 15
Klox Technologies Withdraws IPO 15
Klox Technologies Inc – Key Competitors 16
Klox Technologies Inc – Key Employees 17
Klox Technologies Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Klox Technologies Inc, Pharmaceuticals & Healthcare, Key Facts 2
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Klox Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Klox Technologies Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Klox Technologies Inc, Medical Devices Deals, 2011 to YTD 2017 9
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Leo Pharma Enters into Licensing Agreement with Klox Technologies 11
Klox Technologies Enters Into Licensing Agreement With Sandoz Canada 12
Klox Technologies and LEO Pharma to Form Joint Venture 13
Colgate-Palmolive Enters into Licensing Agreement with Klox Technologies 14
Klox Technologies Withdraws IPO 15
Klox Technologies Inc, Key Competitors 16
Klox Technologies Inc, Key Employees 17
Klox Technologies Inc, Other Locations 18

★海外企業調査レポート[Klox Technologies Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Therabron Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Therabron Therapeutics Inc (Therabron), formerly Clarassance Inc is a clinical-stage biopharmaceutical company that develops drugs based on secretoglobin family of proteins. The company’s lead biopharmaceutical candidate includes CG100, CG201, CG367, CG459 and CG1011. Its CC10 protein candid …
  • Olympia Vodice d.d.:企業の戦略・SWOT・財務情報
    Olympia Vodice d.d. - Strategy, SWOT and Corporate Finance Report Summary Olympia Vodice d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Dominion Resources Inc:発電所・企業SWOT分析
    Dominion Resources Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employ …
  • Seek Limited:企業の戦略・SWOT・財務分析
    Seek Limited - Strategy, SWOT and Corporate Finance Report Summary Seek Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Active Motif Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Active Motif Inc (Active Motif) is a healthcare company that develops and delivers biological research tools. The company’s products include extracts, antibodies, reporter assays, fluorescent dyes, kits, cell, acid, and tissue extracts, molecules and recombinant proteins, among others. It of …
  • Kolon Life Science Inc (102940):製薬・医療:M&Aディール及び事業提携情報
    Summary Kolon Life Science Inc (KLS) focuses on research and development, manufacture and commercialization of pharmaceutical products and active pharmaceutical ingredients (APIs). It develops innovative cell and gene therapeutics. The company's lead product is Invossa, the first cell-mediated gene …
  • Laboratorios Liomont SA de CV:製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratorios Liomont SA de CV (Liomont) is a pharmaceutical company that develops medication products. The company offers prescription medication products, biotech products and over the counter products. It provides drugs in various therapeutic areas including analgesics, antiparasitic, anti …
  • Quest Diagnostics Incorporated:企業のM&A・事業提携・投資動向
    Quest Diagnostics Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Quest Diagnostics Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Alamo Group, Inc.:企業の戦略・SWOT・財務情報
    Alamo Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Alamo Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • First Electric Cooperative Corporation:企業の戦略的SWOT分析
    First Electric Cooperative Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Columbia Power Corp:企業の戦略的SWOT分析
    Columbia Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Jubilant Biosys Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Jubilant Biosys Ltd (Jubilant Biosys), a subsidiary of Jubilant Life Sciences Ltd, is a provider of drug discovery and development solutions. The company offers functional discovery services such as toxicology models, computational chemistry, medicinal chemistry, structural biology, drug met …
  • Callaway Golf Company (ELY):企業の財務・戦略的SWOT分析
    Callaway Golf Company (ELY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • TClarke Plc (CTO):企業の財務・戦略的SWOT分析
    TClarke Plc (CTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Earle M. Jorgensen Company:企業の戦略・SWOT・財務情報
    Earle M. Jorgensen Company - Strategy, SWOT and Corporate Finance Report Summary Earle M. Jorgensen Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • The Bank of Okinawa, Ltd. (8397):企業の財務・戦略的SWOT分析
    The Bank of Okinawa, Ltd. (8397) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Central Alabama Electric Cooperative Inc:企業の戦略的SWOT分析
    Central Alabama Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Suntory Beverage & Food Limited:企業の戦略・SWOT・財務分析
    Suntory Beverage & Food Limited - Strategy, SWOT and Corporate Finance Report Summary Suntory Beverage & Food Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Laboratorio Reig Jofre SA (RJF):製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratorio Reig Jofre SA (Reig Jofre) is a pharmaceutical company that researches, develops, manufactures and markets medicinal products and nutritional supplements. The company’s product categories include specialized technology products, specialty therapeutic areas, and consumer healthcar …
  • Hindustan ZInc Ltd:企業の戦略・SWOT・財務分析
    Hindustan ZInc Ltd - Strategy, SWOT and Corporate Finance Report Summary Hindustan ZInc Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆